GALECTO INC (GLTO) Fundamental Analysis & Valuation

NASDAQ:GLTOUS36322Q2066

Current stock price

28.69 USD
-0.22 (-0.76%)
At close:
29.2 USD
+0.51 (+1.78%)
After Hours:

This GLTO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GLTO Profitability Analysis

1.1 Basic Checks

  • GLTO had negative earnings in the past year.
  • GLTO had a negative operating cash flow in the past year.
  • GLTO had negative earnings in each of the past 5 years.
  • In the past 5 years GLTO always reported negative operating cash flow.
GLTO Yearly Net Income VS EBIT VS OCF VS FCFGLTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • With a Return On Assets value of -147.58%, GLTO is not doing good in the industry: 84.26% of the companies in the same industry are doing better.
  • With a Return On Equity value of -197.88%, GLTO is not doing good in the industry: 69.10% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -147.58%
ROE -197.88%
ROIC N/A
ROA(3y)-103.21%
ROA(5y)-74.46%
ROE(3y)-117.92%
ROE(5y)-83.79%
ROIC(3y)N/A
ROIC(5y)N/A
GLTO Yearly ROA, ROE, ROICGLTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GLTO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GLTO Yearly Profit, Operating, Gross MarginsGLTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024

8

2. GLTO Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, GLTO has more shares outstanding
  • Compared to 5 years ago, GLTO has less shares outstanding
  • GLTO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GLTO Yearly Shares OutstandingGLTO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
GLTO Yearly Total Debt VS Total AssetsGLTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • GLTO has an Altman-Z score of 339.69. This indicates that GLTO is financially healthy and has little risk of bankruptcy at the moment.
  • GLTO's Altman-Z score of 339.69 is amongst the best of the industry. GLTO outperforms 99.62% of its industry peers.
  • GLTO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 339.69
ROIC/WACCN/A
WACCN/A
GLTO Yearly LT Debt VS Equity VS FCFGLTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • GLTO has a Current Ratio of 3.73. This indicates that GLTO is financially healthy and has no problem in meeting its short term obligations.
  • GLTO has a Current ratio (3.73) which is in line with its industry peers.
  • GLTO has a Quick Ratio of 3.73. This indicates that GLTO is financially healthy and has no problem in meeting its short term obligations.
  • GLTO has a Quick ratio (3.73) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.73
Quick Ratio 3.73
GLTO Yearly Current Assets VS Current LiabilitesGLTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. GLTO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 51.73% over the past year.
EPS 1Y (TTM)51.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 15.23% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y94.46%
EPS Next 2Y39.21%
EPS Next 3Y24.16%
EPS Next 5Y15.23%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GLTO Yearly Revenue VS EstimatesGLTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2031 2032 2033 200M 400M 600M
GLTO Yearly EPS VS EstimatesGLTO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80 -100

1

4. GLTO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GLTO. In the last year negative earnings were reported.
  • Also next year GLTO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GLTO Price Earnings VS Forward Price EarningsGLTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GLTO Per share dataGLTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GLTO's earnings are expected to grow with 24.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.21%
EPS Next 3Y24.16%

0

5. GLTO Dividend Analysis

5.1 Amount

  • GLTO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GLTO Fundamentals: All Metrics, Ratios and Statistics

GALECTO INC

NASDAQ:GLTO (3/9/2026, 8:08:32 PM)

After market: 29.2 +0.51 (+1.78%)

28.69

-0.22 (-0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-06
Earnings (Next)03-17
Inst OwnersN/A
Inst Owner Change549.65%
Ins OwnersN/A
Ins Owner Change12.56%
Market Cap1.73B
Revenue(TTM)N/A
Net Income(TTM)-15.84M
Analysts86
Price Target44.88 (56.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.2%
PT rev (3m)37.5%
EPS NQ rev (1m)20.99%
EPS NQ rev (3m)17.95%
EPS NY rev (1m)9.32%
EPS NY rev (3m)8.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 215.81
P/tB 215.81
EV/EBITDA N/A
EPS(TTM)-17.62
EYN/A
EPS(NY)-1.09
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0
BVpS0.13
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -147.58%
ROE -197.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-103.21%
ROA(5y)-74.46%
ROE(3y)-117.92%
ROE(5y)-83.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.73
Quick Ratio 3.73
Altman-Z 339.69
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.38%
EPS Next Y94.46%
EPS Next 2Y39.21%
EPS Next 3Y24.16%
EPS Next 5Y15.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.31%
EBIT Next 3Y-64.3%
EBIT Next 5YN/A
FCF growth 1Y66.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.85%
OCF growth 3YN/A
OCF growth 5YN/A

GALECTO INC / GLTO Fundamental Analysis FAQ

What is the fundamental rating for GLTO stock?

ChartMill assigns a fundamental rating of 3 / 10 to GLTO.


What is the valuation status of GALECTO INC (GLTO) stock?

ChartMill assigns a valuation rating of 1 / 10 to GALECTO INC (GLTO). This can be considered as Overvalued.


How profitable is GALECTO INC (GLTO) stock?

GALECTO INC (GLTO) has a profitability rating of 0 / 10.


What is the expected EPS growth for GALECTO INC (GLTO) stock?

The Earnings per Share (EPS) of GALECTO INC (GLTO) is expected to grow by 94.46% in the next year.